NDC 71329-301-01 - Methylprednisolone Sodium Succinate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71329-301
- Requested NDC
- 71329-301-01
- Package NDCs from labels
- 71329-301-01, 71329-301-25
- Manufacturer
- GeneYork Pharmaceuticals Group LLC | Tianjin Kingyork Pharmaceuticals Co., Ltd
- Effective date
- 2021-04-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| methylPREDNISolone Sodium Succinate for Injection, USP (Rx only) | GeneYork Pharmaceuticals Group LLC | Tianjin Kingyork Pharmaceuticals Co., Ltd | 2021-04-27 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71329-301-25 | 2023-01-30 | C162847 | 48780-1 | f386c649-b168-0266-e053-dadaa90a7c1a | methylPREDNISolone Sodium Succinate for Injection, USP (Rx only) |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Henry Schein, Inc. | ea2f9b6f-2375-40a6-8b97-b607b9f3ac63 | 2026-10-27 | Warnings, Adverse reactions | LEC9GKY20K |
| URIMAR-T CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | cf7c3d65-11d2-49cd-b207-8ccc6a221fe0 | 2026-10-26 | Warnings, Adverse reactions | 593YOG76RN |
| MB CAPS | METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | Allegis Pharmaceuticals, LLC | 2efeb281-b84b-4750-e063-6394a90a27ee | 2026-10-26 | Warnings, Adverse reactions | 593YOG76RN |
| SODIUM PHOSPHATES | SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE AND SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE | Amneal Pharmaceuticals Private Limited | 62db5220-13ec-4cb9-b705-8a908a174dba | 2026-10-16 | Warnings, Adverse reactions | 593YOG76RN |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Cardinal Health 107, LLC | 7e38b09c-da41-4ee3-8f99-812d3276d551 | 2026-10-13 | Warnings, Adverse reactions | LEC9GKY20K |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | REMEDYREPACK INC. | ae524bdb-9fd0-49f9-802d-465a374c175b | 2026-09-08 | Warnings, Adverse reactions | LEC9GKY20K |
| METHYLPREDNISOLONE SODIUM SUCCINATE | METHYLPREDNISOLONE SODIUM SUCCINATE | HF Acquisition Co LLC, DBA HealthFirst | 559427ac-9fc6-96f5-e063-6294a90a0b30 | 2026-07-24 | Warnings, Adverse reactions | ANDA212396 LEC9GKY20K |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Sportpharm LLC | 0cb0ba76-067f-46c4-a5d8-b585d5ecafe3 | 2026-07-23 | Warnings, Adverse reactions | LEC9GKY20K |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Cardinal Health 107, LLC | 68ef8ec4-16de-4a8c-8696-b09359660380 | 2026-07-17 | Warnings, Adverse reactions | LEC9GKY20K |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Pharmacia & Upjohn Company LLC | 7271310c-7764-4812-aa30-a5e90987c7a9 | 2026-06-25 | Warnings, Adverse reactions | LEC9GKY20K |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fd8a72-0527-df0c-e063-6294a90abe75 | 2026-06-24 | 593YOG76RN | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fddca1-b40c-7af0-e063-6294a90a410e | 2026-06-24 | 593YOG76RN | |
| Leukotrap WB System | CPDA-1 BLOOD BAG COLLECTION SYSTEM | GVS TM INC | 54fdf83e-f641-1f69-e063-6394a90ab750 | 2026-06-24 | 593YOG76RN | |
| Methylprednisolone Sodium Succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | Eugia US LLC | 2035f00e-2299-473a-b004-cb93f541cfa9 | 2026-06-12 | Warnings, Adverse reactions | LEC9GKY20K |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | A-S Medication Solutions | 8e5997ed-f4a5-43f7-abbd-c8e2219fe0e9 | 2026-05-29 | Warnings, Adverse reactions | LEC9GKY20K |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Cardinal Health 107, LLC | 2af28649-2553-4bcc-9cb1-c73f7cec76d5 | 2026-05-20 | Warnings, Adverse reactions | LEC9GKY20K |
| Methylprednisolone sodium succinate | METHYLPREDNISOLONE SODIUM SUCCINATE | REMEDYREPACK INC. | f339882f-c380-4022-bdcd-94556a7926aa | 2026-04-15 | Warnings, Adverse reactions | ANDA212396 LEC9GKY20K |
| Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | Rising Pharma Holdings, Inc. | b01eac95-dbe3-4b21-a922-187e0fc8ad23 | 2026-04-07 | Adverse reactions | 22ADO53M6F 593YOG76RN |
| PHOSPHA 250 NEUTRAL | DIBASIC SODIUM PHOSPHATE, MONOBASIC POTASSIUM PHOSPHATE AND MONOBASIC SODIUM PHOSPHATE | Rising Pharma Holdings, Inc. | 9432adfc-6add-4ab4-ae93-2e2daf348be2 | 2026-03-25 | Adverse reactions | 22ADO53M6F 593YOG76RN |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Henry Schein, Inc. | decceb81-e922-4b72-a278-3ed80f4adb04 | 2026-03-18 | Warnings, Adverse reactions | LEC9GKY20K |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.